In another active week for the IPO market, six companies in six different sectors raised over $2 billion. Boasting strong comp growth, National Vision (EYE) was the top performer with a 28% gain as investors put a premium on the...read more
Two IPOs raised a combined $574 million this past week and notched modest gains. Pigments supplier Venator Materials raised $454 million and ultra-rare bone disease biotech Clementia Pharmaceuticals raised $120 million. July 2017 was the ...read more
The US IPO market's 2017 recovery gained momentum in the second quarter, with 52 IPOs raising $11 billion, a two-year high in terms of deal count and proceeds. Just halfway through the year, the 2017 IPO market has raised more capital than all of 2016. Sectors...read more
9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more
US IPO Weekly Recap: Investors eye National Vision in 6-IPO week
In another active week for the IPO market, six companies in six different sectors raised over $2 billion. Boasting strong comp growth, National Vision (EYE) was the top performer with a 28% gain as investors put a premium on the...read more
US IPO Weekly Recap: Two IPOs start off the annual August lull
Two IPOs raised a combined $574 million this past week and notched modest gains. Pigments supplier Venator Materials raised $454 million and ultra-rare bone disease biotech Clementia Pharmaceuticals raised $120 million. July 2017 was the ...read more
Renaissance Capital's 2Q17 US IPO Market Review
The US IPO market's 2017 recovery gained momentum in the second quarter, with 52 IPOs raising $11 billion, a two-year high in terms of deal count and proceeds. Just halfway through the year, the 2017 IPO market has raised more capital than all of 2016. Sectors...read more
US IPO Weekly Recap: Floor & Décor pops 53%, Carvana skids 26%
9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more